TP53 and colorectal carcinoma: Although CRC patients in both subtypes have a similar mutation frequency of APC and TP53 in the COSMIC dataset, MSI-H CRCs were observed to harbor more APC and TP53 mutations per patient sample as compared to patients in the non-MSI-H cohort (Figure 3C).